Our top pick for
This article contains links to products or services from one or more of our advertisers or partners. We may receive a commission when you click or make a purchase using our site. Learn more about how we make money.
PetMed Express, Inc is a pharmaceutical retailers business based in the US. PetMed Express shares (PETS) are listed on the NASDAQ and all prices are listed in US Dollars. PetMed Express employs 214 staff and has a trailing 12-month revenue of around USD$300.3 million.
|Latest market close||USD$30|
|52-week range||USD$18.85 - USD$42.885|
|50-day moving average||USD$31.7154|
|200-day moving average||USD$33.6787|
|Wall St. target price||USD$32.5|
|Dividend yield||USD$1.12 (3.41%)|
|Earnings per share (TTM)||USD$1.415|
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2020-11-25)||-0.30%|
|1 month (2020-11-06)||0.37%|
|3 months (2020-09-04)||-1.43%|
|6 months (2020-06-05)||-14.58%|
|1 year (2019-12-05)||36.99%|
|2 years (2018-12-04)||28.10%|
|3 years (2017-12-05)||-28.35%|
|5 years (2015-12-04)||74.62%|
Valuing PetMed Express stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of PetMed Express's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
PetMed Express's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 23x. In other words, PetMed Express shares trade at around 23x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
PetMed Express's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.58. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into PetMed Express's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
PetMed Express's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$36.7 million.
The EBITDA is a measure of a PetMed Express's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||USD$300.3 million|
|Operating margin TTM||11.48%|
|Gross profit TTM||USD$81.2 million|
|Return on assets TTM||14.02%|
|Return on equity TTM||22.05%|
|Market capitalisation||USD$717 million|
TTM: trailing 12 months
There are currently 6.3 million PetMed Express shares held short by investors – that's known as PetMed Express's "short interest". This figure is 7.9% up from 5.8 million last month.
There are a few different ways that this level of interest in shorting PetMed Express shares can be evaluated.
PetMed Express's "short interest ratio" (SIR) is the quantity of PetMed Express shares currently shorted divided by the average quantity of PetMed Express shares traded daily (recently around 519993.6416185). PetMed Express's SIR currently stands at 12.11. In other words for every 100,000 PetMed Express shares traded daily on the market, roughly 12110 shares are currently held short.
However PetMed Express's short interest can also be evaluated against the total number of PetMed Express shares, or, against the total number of tradable PetMed Express shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case PetMed Express's short interest could be expressed as 0.31% of the outstanding shares (for every 100,000 PetMed Express shares in existence, roughly 310 shares are currently held short) or 0.3857% of the tradable shares (for every 100,000 tradable PetMed Express shares, roughly 386 shares are currently held short).
A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against PetMed Express.
Find out more about how you can short PetMed Express stock.
Dividend payout ratio: 78.01% of net profits
Recently PetMed Express has paid out, on average, around 78.01% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 3.41% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), PetMed Express shareholders could enjoy a 3.41% return on their shares, in the form of dividend payments. In PetMed Express's case, that would currently equate to about $1.12 per share.
PetMed Express's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
PetMed Express's most recent dividend payout was on 7 August 2020. The latest dividend was paid out to all shareholders who bought their shares by 30 July 2020 (the "ex-dividend date").
PetMed Express's shares were split on a 3:1 basis on 4 March 1999. So if you had owned 1 share the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your PetMed Express shares – just the quantity. However, indirectly, the new 66.7% lower share price could have impacted the market appetite for PetMed Express shares which in turn could have impacted PetMed Express's share price.
Over the last 12 months, PetMed Express's shares have ranged in value from as little as $18.85 up to $42.885. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while PetMed Express's is 0.6977. This would suggest that PetMed Express's shares are less volatile than average (for this exchange).
PetMed Express, Inc., together with its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, and other health products for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventative, flea and tick preventative, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, strollers, and other pet supplies. It sells its products through its Internet website; telephone contact center; and direct mail/print through brochures and postcards. PetMed Express, Inc. was founded in 1996 and is headquartered in Delray Beach, Florida.
Steps to owning and managing HTZ, with 24-hour and historical pricing before you buy.
Steps to owning and managing HELE, with 24-hour and historical pricing before you buy.
Steps to owning and managing HE, with 24-hour and historical pricing before you buy.
Steps to owning and managing GKOS, with 24-hour and historical pricing before you buy.
Steps to owning and managing EYEN, with 24-hour and historical pricing before you buy.
Steps to owning and managing EXAS, with 24-hour and historical pricing before you buy.
Steps to owning and managing EVFM, with 24-hour and historical pricing before you buy.
Steps to owning and managing MRAM, with 24-hour and historical pricing before you buy.
Steps to owning and managing EQNR, with 24-hour and historical pricing before you buy.
Steps to owning and managing SOLO, with 24-hour and historical pricing before you buy.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.